Show simple item record

dc.contributor.authorSandra, Namyalo
dc.date.accessioned2023-10-11T10:16:23Z
dc.date.available2023-10-11T10:16:23Z
dc.date.issued2023-09
dc.identifier.citationNamyalo, S. 2023. Factors associated with loss to follow up among HIV positive clients started on anti-retroviral therapy under the test-and treat treatment guidelines in Luwero District ( Unpublished Masters dissertation ). Makerere University, Kampala, Uganda.en_US
dc.identifier.urihttp://hdl.handle.net/10570/12192
dc.descriptionA proposal submitted to Makerere university school of public health in partial fulfillment of the requirements for the award of master of public healthen_US
dc.description.abstractIntroduction: Following the World Health Organization (WHO) recommendations in 2015 that all persons diagnosed with human immunodeficiency virus (HIV) be started on antiretroviral therapy (ART) immediately termed as Test-and-treat, the number of people who are initiated on ART increased. There is a possibility that a surge in patient numbers coupled with initiation of largely asymptomatic patients as a result of test-and-treat, might accelerate the likelihood of patients getting loss to follow up (LTFU). This study seeks to determine factors associated with LTFU among patients following ART initiation in the test-and-treat era.Methods: This was unmatched case control study of 234 (78 cases 156 controls) patients drawn from routine patients‘ data for HIV clients enrolled in January – March 2020 in selected high volume facilities in Luwero District. Logistic regression was used to identify factors associated with lost to follow up. The results were further supported by Key informant interviews to explore the perceptions of health workers toward the test-and-treat policy and the risk of LTFU.Results: Overall, females accounted for more than 50% of the study participants in both groups. The Median age (IQR) was 30.5(25-39) among cases and 31.5(26-40.5) among controls. Majority of the study participants were married with more than 50% in both groups. The factors associated with LTFU were earning >30,000 (95% CI, 1.58-13.40), receiving care from government facilities (aOR=2.57, 95% CI, 1.16-5.67), spending limited time with health workers (aOR=3.97, 95% CI, 1.10-14.37 and HIV clinics have long patients‘ queues (aOR=2.41, 95% CI, 0.97-6.00). Inadequate counselling and transport issues were the prominent reasons for LTFU reported from Key informant interviews. Conclusion: Findings from the study indicate that delays for people living with HIV to enroll into HIV care and treatment and same day initiation of ART are not associated with loss to follow up. The factors associated with loss to follow up included participants who earneden_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectHIV positive clientsen_US
dc.subjectHIVen_US
dc.subjectanti-retroviralen_US
dc.subjectanti-retroviral therapyen_US
dc.subjecton anti-retroviral therapy under the test-and treat treatmenten_US
dc.subjectLuwero Districten_US
dc.titleFactors associated with loss to follow up among HIV positive clients started on anti-retroviral therapy under the test-and treat treatment guidelines in Luwero Districten_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record